Regenicin (Regenicin) Shares Buyback Ratio % : 0.00 (As of May. 24, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Regenicin Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Regenicin's current shares buyback ratio was 0.00%.

Regenicin Shares Buyback Ratio % Historical Data

The historical data trend for Regenicin's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenicin Shares Buyback Ratio % Chart

Regenicin Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Shares Buyback Ratio %

Get a 7-Day Free Trial

Regenicin Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-	-	-

Regenicin Shares Buyback Ratio % Calculation

Regenicin's Shares Buyback Ratio for the fiscal year that ended in Sep. 2022 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Sep. 2021 )	-	Shares Outstanding (EOP) (A: Sep. 2022 ))	/	Shares Outstanding (EOP) (A: Sep. 2021 )
	=	(153.483	-	153.483)	/	153.483
	=	0.00%

Regenicin's Shares Buyback Ratio for the quarter that ended in Mar. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Mar. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(153.483	-	153.483)	/	153.483
	=	0.00%

Regenicin Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Regenicin's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Regenicin (Regenicin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenicin Inc (OTCPK:RGIN) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 High Court, Little Falls, NJ, USA, 07424

Website

https://www.regenicin.com

Regenicin Inc is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Its skin substitute product candidate comprises of NovaDerm. NovaDerm is a multi-layered tissue-engineered living skin prepared by utilizing autologous (patient's own) skin cells. It is a graftable cultured epithelium skin substitute containing both epidermal and dermal components with a collagen base. The technology has been clinically tested in Hundreds of pediatric, catastrophic burn patients.

Regenicin (Regenicin) Headlines

No Headlines